Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.(688505)

8.93+0.23+2.64%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Fudanzhangjiang (01349) Subscribes to China Merchants Bank Structured Deposit Products
  Stock News · 01-07
  Fudanzhangjiang (01349) Subscribes to China Merchants Bank Structured Deposit Products
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical- Subscription of Structured Deposit Product Under Ping an Bank of RMB270 Mln
  THOMSON REUTERS · 01-07
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical- Subscription of Structured Deposit Product Under Ping an Bank of RMB270 Mln
- BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Enters Bank Of China Structured Deposit Product Agreement
  Reuters · 01-06
  BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Enters Bank Of China Structured Deposit Product Agreement
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Principal Amount of Subscription RMB150 Million
  THOMSON REUTERS · 01-06
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Principal Amount of Subscription RMB150 Million
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Bank of China Structured Deposit Product Agreement With Bank of China
  THOMSON REUTERS · 01-06
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical - Bank of China Structured Deposit Product Agreement With Bank of China
- Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd And 2 Other Asian Penny Stocks To Watch Closely
  Simply Wall St. · 01-06
  Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd And 2 Other Asian Penny Stocks To Watch Closely
- Fudan-Zhangjiang Bio-Pharmaceutical Invests 210 Million Yuan in Structured Deposit Product
  MT Newswires Live · 01-05
  Fudan-Zhangjiang Bio-Pharmaceutical Invests 210 Million Yuan in Structured Deposit Product
- FUDANZHANGJIANG (01349) Subscribes to Structured Deposit Products Totaling RMB 210 Million with SPD Bank
  Stock News · 01-04
  FUDANZHANGJIANG (01349) Subscribes to Structured Deposit Products Totaling RMB 210 Million with SPD Bank
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Gets NMPA Acceptance for FZ-P001 Phase II Lung Cancer Trial
  Reuters · 2025-12-28
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Gets NMPA Acceptance for FZ-P001 Phase II Lung Cancer Trial
- FUDANZHANGJIANG (01349): Qu Yanan Elected as Employee Director
  Stock News · 2025-11-26
  FUDANZHANGJIANG (01349): Qu Yanan Elected as Employee Director
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Files Director List to HKEX
  Reuters · 2025-11-26
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Files Director List to HKEX
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. held extraordinary general meeting
  Reuters · 2025-11-26
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. Ltd. held extraordinary general meeting
- FUDANZHANGJIANG (01349) Shareholder Yang Zongmeng Plans to Sell Up to Approximately 10.37 Million Shares
  Stock News · 2025-11-04
  FUDANZHANGJIANG (01349) Shareholder Yang Zongmeng Plans to Sell Up to Approximately 10.37 Million Shares
- Shareholders to Vote on Change in Use of IPO Proceeds at Next Shanghai Fudan-Zhangjiang Bio-Pharmaceutical EGM
  Reuters · 2025-10-31
  Shareholders to Vote on Change in Use of IPO Proceeds at Next Shanghai Fudan-Zhangjiang Bio-Pharmaceutical EGM
- FUDANZHANGJIANG (01349) Reports Net Loss of RMB15.94 Million for First Three Quarters, Shifting from Profit to Loss YoY
  Stock News · 2025-10-30
  FUDANZHANGJIANG (01349) Reports Net Loss of RMB15.94 Million for First Three Quarters, Shifting from Profit to Loss YoY
- Fudan Zhangjiang's Obeticholic Acid Generic Drug Fails, 125 Million R&D Investment Wasted: What Risks Are Hidden Behind?
  Deep News · 2025-10-17
  Fudan Zhangjiang's Obeticholic Acid Generic Drug Fails, 125 Million R&D Investment Wasted: What Risks Are Hidden Behind?
- Fudan Zhangjiang (01349) Invests RMB 100 Million in Structured Deposit Product from China Merchants Bank
  Stock News · 2025-10-15
  Fudan Zhangjiang (01349) Invests RMB 100 Million in Structured Deposit Product from China Merchants Bank
- BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Says Group Agreed To Subscribe For Structured Deposit Products For RMB100 Million
  Reuters · 2025-10-15
  BRIEF-Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Says Group Agreed To Subscribe For Structured Deposit Products For RMB100 Million
- Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Group Agreed to Subscribe for Structured Deposit Products for RMB100 Mln
  THOMSON REUTERS · 2025-10-15
  Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd - Group Agreed to Subscribe for Structured Deposit Products for RMB100 Mln
- FUDANZHANGJIANG (01349) Subscribes to RMB 170 Million Structured Deposit Products
  Stock News · 2025-10-14
  FUDANZHANGJIANG (01349) Subscribes to RMB 170 Million Structured Deposit Products
Company Profile
Company Name
上海复旦张江生物医药股份有限公司
Industry
医药制造业
Listing Date
2020-06-19
Registered Capital
10365万元
Introduction
上海复旦张江生物医药股份有限公司的主营业务是生物医药的创新研究开发、生产制造和市场营销。公司的主要产品是皮肤科产品、抗肿瘤产品。

1D
5D
Day
Week
Month

Loading ...

High

8.93

Open

8.71

T/O Rate

1.07%

Low

8.68

8.70

Amplitude

2.87%

To The Moon

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.(688505)

Company Profile

Most Discussed